Delivery Order SPE2DB22D3501-SPE2DB25FVE29
Award Date
4/7/25
Potential Completion Date
4/8/25
Potential Value
$6.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $22,802.68 and a period of performance through January 7, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DB22D1106|SPE2DB25FDJP3, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $3,212.70 firm fixed-price delivery order is for the supply of 4566293159 CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. There is no set-aside designation specified. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) to supply CATHFLO ACTIVASE 2 MG VIALS for a total ceiling value of $6,801.93. The contract is a Delivery Order with a Firm Fixed Price pricing type, set to expire on February 3, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,272.76, is a Firm Fixed Price Delivery Order for the supply of CATHFLO ACTIVASE 2 MG VIALS. The contract has an ultimate completion date of March 14, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award and has no major subcontractors mentioned. The contract is not designated...
This federal contract award, with a ceiling value of $3,353.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a pharmaceutical product, with a period of performance through July 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $5,429.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 16, 2025. The contract is for the procurement of CATHFLO ACTIVASE 2 MG VIALS, a critical medical commodity supporting the healthcare needs of military personnel, veterans, and other...
This federal contract award, valued at $3,730.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a medical product. The award is a Delivery Order contract with a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition. The contract has an ultimate completion date of February 7, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $15,870.89 and an ultimate completion date of March 7, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of CATHFLO ACTIVASE 2 MG VIALS. The contract has a ceiling value of $6,506.90 and a period of performance through April 3, 2024. This award is a task order under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, with a potential value of...
This federal contract award, valued at $2,141.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CATHFLO ACTIVASE 2 MG VIALS, a critical medical product, with a performance period through October 2024. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...